Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2012; 18(8): 778-784
Published online Feb 28, 2012. doi: 10.3748/wjg.v18.i8.778
Figure 1
Figure 1 Cyclooxygenase-2 expression in gastric cancer, diffuse histotype. Lymph node expression is significantly higher than in the stomach (Median scores). aP = 0.0108, Mann-Whitney test. COX-2: Cyclooxygenase-2.
Figure 2
Figure 2 Cyclooxygenase-2 expression in primary diffuse gastric cancer and respective metastasis. Lymph node expression is higher than stomach expression levels in most cases (Individual case scores). P = 0.0137, Wilcoxon paired test. 2x means two overlaid cases. COX-2: Cyclooxygenase-2.
Figure 3
Figure 3 Cyclooxygenase-2 expression in gastric cancer. A, B: Intestinal type, case 12; A: Stomach = score 1, cancer cells were negative or scarcely stained (*). Strong cyclooxygenase-2 staining of inflammatory cells (mononuclear) into the stroma (arrows); B: Lymph node = score 8; C, D: Diffuse type, case 3; C: Stomach = score 4; D: Lymph node = score 12; E, F: Mixed type, case 7; E: Stomach = score 8 (both components); F: Lymph node = score 12; G, H: Unclassified, case 5; G: Stomach = score 6; H: Lymph node = score 8. All magnifications 400 ×.
Figure 4
Figure 4 Cyclooxygenase-2 expression in gastric cancer and diffuse type: primary tumor, emboli and metastasis. A: Stomach: Low cyclooxygenase-2 (COX-2) expression in perivascular malignant cells (arrows). Tumor embolus with strongly stained neoplastic cells (*); B: Lymph node: High COX-2 expression at the same intensity seen in the embolus. Case 3, diffuse histotype, 400 ×.